Webinar: Innovation in electronic signature: Iris biometrics as a solution in GMP environments
“Innovation in electronic signature: Iris biometrics as a solution in GMP environments”, a webinar dedicated to present and evaluate how biometric technology is transforming security and regulatory compliance in the pharmaceutical industry.
Webinar organized by Verazial Labs and Ambit BST
On September 18, 2024, we hosted a webinar with our partners Ambit BST, titled “Innovation in electronic signatures: Iris biometrics as a solution in GMP environments”.
Emilio Gallego, Founder and CEO of Verazial Labs, presented the advances in the implementation of iris biometrics and its impact on improving the security and reliability of electronic signatures. Anna Dachs, consultant at Ambit BST, discussed the regulatory implications, highlighting how this technology aligns with data integrity requirements in GMP environments.
The webinar served as a platform to deeply analyze the challenges currently faced in employee identification within the pharmaceutical sector, a critical issue that directly impacts the traceability and accuracy of data generated during production processes. The absence of a robust identification system can compromise the integrity of recorded data and, consequently, affect compliance with the strict regulations governing this industry, such as Good Manufacturing Practices (GMP). Errors or gaps in employee authentication not only create operational risks but also legal liabilities, which can result in warning letters, penalties, and a loss of trust from both clients and end consumers.
In this context, the increasing importance of implementing electronic signatures with biometric technologies, such as iris biometrics, was highlighted. These solutions not only ensure precise, fast, secure, and convenient identification but also guarantee complete traceability of every action taken during processes, enabling more rigorous and reliable control. Accuracy and data integrity are essential for regulatory compliance, and biometric electronic signatures provide an additional layer of security, reducing the risk of forgery or document manipulation.
During the webinar, the importance of companies adopting a philosophy focused on quality was mentioned, not only to comply with current regulations, but also to position themselves as leaders in the industry. By implementing these solutions, they seek to achieve the highest quality standards at every stage of their operations, ensuring that the excellence of their final products distinguishes them from the competition and consolidates their leadership in the market.
In addition, an implementation case was shared in which Verazial Labs is currently working with a large pharmaceutical company in India. Through this solution, the company aims not only to meet regulatory requirements but also to position itself as a leader in operational quality. The goal is to significantly improve its employee identification processes, ensuring the security of access to machinery and the integrity of the data collected.
For those who were unable to attend live, the webinar is available on our partner YouTube channel, where you can discover more about this innovative technology solution that is transforming the way the pharmaceutical industry manages its electronic signature processes in highly regulated environments.
Webinar: Innovation in electronic signature: Iris biometrics as a solution in GMP environments
“Innovation in electronic signature: Iris biometrics as a solution in GMP environments”, a webinar dedicated to present and evaluate how biometric technology is transforming security and regulatory compliance in the pharmaceutical industry.
Webinar organized by Verazial Labs and Ambit BST
On September 18, 2024, we hosted a webinar with our partners Ambit BST, titled “Innovation in electronic signatures: Iris biometrics as a solution in GMP environments”.
Emilio Gallego, Founder and CEO of Verazial Labs, presented the advances in the implementation of iris biometrics and its impact on improving the security and reliability of electronic signatures. Anna Dachs, consultant at Ambit BST, discussed the regulatory implications, highlighting how this technology aligns with data integrity requirements in GMP environments.
The webinar served as a platform to deeply analyze the challenges currently faced in employee identification within the pharmaceutical sector, a critical issue that directly impacts the traceability and accuracy of data generated during production processes. The absence of a robust identification system can compromise the integrity of recorded data and, consequently, affect compliance with the strict regulations governing this industry, such as Good Manufacturing Practices (GMP). Errors or gaps in employee authentication not only create operational risks but also legal liabilities, which can result in warning letters, penalties, and a loss of trust from both clients and end consumers.
In this context, the increasing importance of implementing electronic signatures with biometric technologies, such as iris biometrics, was highlighted. These solutions not only ensure precise, fast, secure, and convenient identification but also guarantee complete traceability of every action taken during processes, enabling more rigorous and reliable control. Accuracy and data integrity are essential for regulatory compliance, and biometric electronic signatures provide an additional layer of security, reducing the risk of forgery or document manipulation.
During the webinar, the importance of companies adopting a philosophy focused on quality was mentioned, not only to comply with current regulations, but also to position themselves as leaders in the industry. By implementing these solutions, they seek to achieve the highest quality standards at every stage of their operations, ensuring that the excellence of their final products distinguishes them from the competition and consolidates their leadership in the market.
In addition, an implementation case was shared in which Verazial Labs is currently working with a large pharmaceutical company in India. Through this solution, the company aims not only to meet regulatory requirements but also to position itself as a leader in operational quality. The goal is to significantly improve its employee identification processes, ensuring the security of access to machinery and the integrity of the data collected.
For those who were unable to attend live, the webinar is available on our partner YouTube channel, where you can discover more about this innovative technology solution that is transforming the way the pharmaceutical industry manages its electronic signature processes in highly regulated environments.
Webinar: Innovation in electronic signature: Iris biometrics as a solution in GMP environments
“Innovation in electronic signature: Iris biometrics as a solution in GMP environments”, a webinar dedicated to present and evaluate how biometric technology is transforming security and regulatory compliance in the pharmaceutical industry.
Webinar organized by Verazial Labs and Ambit BST
On September 18, 2024, we hosted a webinar with our partners Ambit BST, titled “Innovation in electronic signatures: Iris biometrics as a solution in GMP environments”.
Emilio Gallego, Founder and CEO of Verazial Labs, presented the advances in the implementation of iris biometrics and its impact on improving the security and reliability of electronic signatures. Anna Dachs, consultant at Ambit BST, discussed the regulatory implications, highlighting how this technology aligns with data integrity requirements in GMP environments.
The webinar served as a platform to deeply analyze the challenges currently faced in employee identification within the pharmaceutical sector, a critical issue that directly impacts the traceability and accuracy of data generated during production processes. The absence of a robust identification system can compromise the integrity of recorded data and, consequently, affect compliance with the strict regulations governing this industry, such as Good Manufacturing Practices (GMP). Errors or gaps in employee authentication not only create operational risks but also legal liabilities, which can result in warning letters, penalties, and a loss of trust from both clients and end consumers.
In this context, the increasing importance of implementing electronic signatures with biometric technologies, such as iris biometrics, was highlighted. These solutions not only ensure precise, fast, secure, and convenient identification but also guarantee complete traceability of every action taken during processes, enabling more rigorous and reliable control. Accuracy and data integrity are essential for regulatory compliance, and biometric electronic signatures provide an additional layer of security, reducing the risk of forgery or document manipulation.
During the webinar, the importance of companies adopting a philosophy focused on quality was mentioned, not only to comply with current regulations, but also to position themselves as leaders in the industry. By implementing these solutions, they seek to achieve the highest quality standards at every stage of their operations, ensuring that the excellence of their final products distinguishes them from the competition and consolidates their leadership in the market.
In addition, an implementation case was shared in which Verazial Labs is currently working with a large pharmaceutical company in India. Through this solution, the company aims not only to meet regulatory requirements but also to position itself as a leader in operational quality. The goal is to significantly improve its employee identification processes, ensuring the security of access to machinery and the integrity of the data collected.
For those who were unable to attend live, the webinar is available on our partner YouTube channel, where you can discover more about this innovative technology solution that is transforming the way the pharmaceutical industry manages its electronic signature processes in highly regulated environments.
